Research analysts covering IR-Med.
Recent press releases and 8-K filings for IRME.
IR-Med, Inc. converts outstanding debt into common stock
IRME
- On September 5, 2025, IR-Med, Inc. entered into amendments to several loan agreements, converting $155,437 in outstanding debt, including accrued interest, into common stock.
- A total of 11,956,692 shares of the Company's common stock were issued at a fixed conversion price of $0.013 per share.
- The debt conversion involved lenders including Yaniv Cohen and Aharon Klein, both directors of the Company, and M2bwell LTD.
- The amended agreements included the 2015 Loan Agreement, 2017 Shareholders’ Loan Agreement, and 2018 Convertible Bridge Loan Agreement, with the debts under these agreements now fully satisfied and terminated.
Sep 11, 2025, 8:05 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more